Charles River Laboratories International Stock Price and Value Analysis

Should you buy Charles River Laboratories International stock? (NYSE:CRL). Let's see how it does in our automated value investing analysis system.

AdvantagesDisadvantagesNeutral
  • This company has amazingly consistent growth!
  • This company is less known than others.
  • This stock looks overpriced.
  • This company is making money at a modest rate.
  • This company pays no dividend.

Inside the CRL Numbers

CRL Price
(Charles River Laboratories International stock price per share)
$115.97
[?] CRL Fair Price
(based on intrinsic value)
$65.48
[?] CRL Safety Price (based on a variable margin of safety) $39.29
[?] PE Ratio versus Sector 116% higher than other Healthcare stocks
[?] PE Ratio versus Industry 78% lower than other Diagnostics & Research stocks
[?] Cash Yield 5.06%
[?] Free Cash Flow Jitter 12%

Is Charles River Laboratories International Stock on Sale?

We believe that Charles River Laboratories International may be worth examining further. It's making money, which is a very positive sign. Is it on sale?

Charles River Laboratories International looks overpriced right now. If you're looking for a bargain in the stock market, you should probably look elsewhere for a great deal. This might still be a great stock to own—but it's not on sale right now.

Should You Buy CRL Stock?

Does Charles River Laboratories International have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.